Literature DB >> 31879180

Structural insights into the active site of poly(ADP-ribose) glycohydrolase using docking modes of 6-hydroxy-3H-xanthen-3-one derivative inhibitors.

Yuto Shibui1, Takahiro Oyama2, Miwa Okazawa3, Atsushi Yoshimori4, Hideaki Abe2, Fumiaki Uchiumi1, Sei-Ichi Tanuma5.   

Abstract

Poly(ADP-ribose) glycohydrolase (PARG) plays an essential role in poly(ADP-ribose) (PAR) turnover, and thereby regulating DNA transactions, such as DNA repair, replication, transcription and recombination. Here, we examined the inhibitory activities of 6-hydroxy-3H-xanthene-3-one (HXO) derivatives and analyzed their binding modes in the active site of PARG by in silico docking study. Among the derivatives, Rose Bengal was found to be the most potent inhibitor of PARG and its halogen groups were revealed to cooperatively potentiate the inhibitory activity. Importantly, the binding mode of Rose Bengal occupied the active site of PARG revealed the presence of unique "Sandwich" residues of Asn869 and Tyr792, which enable the inhibitor to bind tightly with the active pocket. This sandwich interaction could stabilize the π-π interactions of HXO scaffold with Phe902 and Tyr795. In addition, to increase the binding affinity, the iodine and chlorine atoms of this inhibitor could contribute to the inducing of favorable disorders, which promote an entropy boost on the active site of PARG for structural plasticity, and making the stable configuration of HXO scaffold in the active site, respectively, as judged by the analysis of binding free energy. These results provide new insights into the active site of PARG and an additional opportunity for designing selective PARG inhibitors.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Active site; Docking study; Inhibitor; Poly(ADP-ribose) glycohydrolase; Rose Bengal

Year:  2019        PMID: 31879180     DOI: 10.1016/j.bmc.2019.115249

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling.

Authors:  Sei-Ichi Tanuma; Takahiro Oyama; Miwa Okazawa; Hiroaki Yamazaki; Koichi Takao; Yoshiaki Sugita; Shigeru Amano; Takehiko Abe; Hiroshi Sakagami
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

2.  A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling.

Authors:  Hideaki Abe; Miwa Okazawa; Takahiro Oyama; Hiroaki Yamazaki; Atsushi Yoshimori; Takanori Kamiya; Mitsutoshi Tsukimoto; Koichi Takao; Yoshiaki Sugita; Hiroshi Sakagami; Takehiko Abe; Sei-Ichi Tanuma
Journal:  Medicines (Basel)       Date:  2021-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.